DK3528825T3 - Fremgangsmåder og sammensætninger til ændring af sammensætningen af hudmikrobiomet under anvendelse af komplekse blandinger af bakteriestammer - Google Patents
Fremgangsmåder og sammensætninger til ændring af sammensætningen af hudmikrobiomet under anvendelse af komplekse blandinger af bakteriestammer Download PDFInfo
- Publication number
- DK3528825T3 DK3528825T3 DK17835861.0T DK17835861T DK3528825T3 DK 3528825 T3 DK3528825 T3 DK 3528825T3 DK 17835861 T DK17835861 T DK 17835861T DK 3528825 T3 DK3528825 T3 DK 3528825T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- changing
- composition
- methods
- complex mixtures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410329P | 2016-10-19 | 2016-10-19 | |
| US201762536761P | 2017-07-25 | 2017-07-25 | |
| PCT/IB2017/001481 WO2018073651A1 (en) | 2016-10-19 | 2017-10-19 | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3528825T3 true DK3528825T3 (da) | 2021-08-30 |
Family
ID=61054421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17835861.0T DK3528825T3 (da) | 2016-10-19 | 2017-10-19 | Fremgangsmåder og sammensætninger til ændring af sammensætningen af hudmikrobiomet under anvendelse af komplekse blandinger af bakteriestammer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11541081B2 (da) |
| EP (2) | EP3528825B1 (da) |
| JP (1) | JP7235654B2 (da) |
| KR (1) | KR102584057B1 (da) |
| CN (1) | CN110352065A (da) |
| CA (1) | CA3040814A1 (da) |
| DK (1) | DK3528825T3 (da) |
| ES (2) | ES2967029T3 (da) |
| MX (1) | MX2019004611A (da) |
| PL (2) | PL3528825T3 (da) |
| WO (1) | WO2018073651A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3360560A1 (en) * | 2012-03-17 | 2018-08-15 | The Regents of the University of California | Composition for treating acne |
| CA3021690A1 (en) | 2015-04-20 | 2016-10-27 | S-Biomedic Nv | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains |
| ES2967029T3 (es) * | 2016-10-19 | 2024-04-25 | S Biomedic Nv | Métodos y composiciones para cambiar la composición del microbioma de la piel usando mezclas complejas de cepas bacterianas |
| KR20200019116A (ko) * | 2017-03-10 | 2020-02-21 | 프로더믹, 인코포레이티드 | 피부 균총의 분석에 기반한 맞춤형 피부 케어 제품 및 개인 케어 제품 |
| MX2020013073A (es) * | 2018-06-14 | 2021-05-27 | Beiersdorf Ag | Preparacion cosmetica contra el acne. |
| JP7532361B2 (ja) | 2018-11-16 | 2024-08-13 | エス－バイオメディック・エン．ヴェー． | 酸化ストレスに関連付けられる皮膚疾患及び皮膚老化を処置するための組成物ならびに酸化ストレスに関連付けられる皮膚疾患の診断。 |
| BR112022006342A2 (pt) | 2019-10-03 | 2022-06-28 | S Biomedic | Composição inovadora de cuidados com a pele |
| CN114929193A (zh) * | 2019-10-03 | 2022-08-19 | S-生物医药有限公司 | 新的皮肤护理组合物 |
| CN114901252A (zh) | 2019-10-03 | 2022-08-12 | S-生物医药有限公司 | 新的皮肤护理组合物 |
| US20220354776A1 (en) | 2019-10-03 | 2022-11-10 | Beiersdorf Ag | Novel skin care composition |
| BR112022006369A2 (pt) | 2019-10-03 | 2022-06-28 | S Biomedic | Composição inovadora para cuidados com a pele |
| BR112022006345A2 (pt) | 2019-10-03 | 2022-06-28 | S Biomedic | Composição inovadora para cuidados com a pele |
| CN114901246A (zh) * | 2019-10-03 | 2022-08-12 | S-生物医药有限公司 | 新的皮肤护理组合物 |
| CN110846375B (zh) * | 2019-10-23 | 2023-05-05 | 深圳艾尔生物科技有限公司 | 一种用于细菌电阻计数的培养基组合物、制备方法及其应用 |
| US11197824B2 (en) * | 2020-01-16 | 2021-12-14 | David Changaris | Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus |
| AU2022416748A1 (en) | 2021-12-17 | 2024-06-13 | S-Biomedic | A freeze-dried composition and preparation thereof |
| EP4197523A1 (en) | 2021-12-17 | 2023-06-21 | DSM IP Assets B.V. | A freeze-dried composition and preparation thereof |
| WO2023135186A1 (en) | 2022-01-12 | 2023-07-20 | S-Biomedic Nv | Skin care composition and uses thereof |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69310339T2 (de) | 1993-02-19 | 1997-08-21 | Philippe Djian | Präparate, die Corneozyt Proteine enthalten |
| JP3606580B2 (ja) | 1993-12-15 | 2005-01-05 | 株式会社アドバンス | 化粧料 |
| US6743609B1 (en) | 1997-12-23 | 2004-06-01 | Arkion Life Sciences Llc | Linoleate isomerase |
| US6821770B1 (en) | 1999-05-03 | 2004-11-23 | Gen-Probe Incorporated | Polynucleotide matrix-based method of identifying microorganisms |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| US6794537B1 (en) | 2002-11-07 | 2004-09-21 | Sami Labs Limited | Manufacturing processes for Se-methyl-L-selenocysteine |
| CA2612408A1 (en) | 2005-06-15 | 2006-12-28 | Apollo Pharmaceutical, Inc. | Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis |
| WO2009018447A2 (en) | 2007-07-31 | 2009-02-05 | New York University | Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions |
| WO2010013182A1 (en) | 2008-07-29 | 2010-02-04 | L'oreal | Cosmetic use of microorganism(s) for the treatment of scalp disorders |
| US8313782B2 (en) | 2008-12-18 | 2012-11-20 | Guthery B Eugene | Acne vulgaris treatment regimen |
| US20100260695A1 (en) | 2009-04-09 | 2010-10-14 | Mary Kay Inc. | Combination of plant extracts to improve skin tone |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| ITPR20110035A1 (it) | 2011-05-06 | 2012-11-07 | Bormioli Rocco & Figlio Spa | Capsula. |
| WO2013067185A1 (en) | 2011-11-02 | 2013-05-10 | Bios Llc | Probiotic stick formulation for skin maintenance and methods of use |
| EP3360560A1 (en) | 2012-03-17 | 2018-08-15 | The Regents of the University of California | Composition for treating acne |
| AU2014275025B2 (en) | 2013-06-05 | 2016-12-01 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US20150037285A1 (en) | 2013-07-03 | 2015-02-05 | New York University | Methods for efficient transfer of viable and bioactive microbiota |
| US20150050245A1 (en) | 2013-08-14 | 2015-02-19 | Tntgamble, Inc. | Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora |
| EP4219679A3 (en) * | 2014-04-15 | 2023-08-09 | Aobiome LLC | Ammonia-oxidizing nitrosomonas eutropha strain d23 |
| WO2015171899A1 (en) * | 2014-05-07 | 2015-11-12 | The Regents Of The University Of California | Compositions and methods for treating skin and mucous membrane diseases |
| JP2017521059A (ja) | 2014-06-17 | 2017-08-03 | ザイクローブ セラピューティクス, インク.Xycrobe Therapeutics, Inc. | 機械的に位置合わせされた光学的要素及びその製造方法 |
| CA3021690A1 (en) * | 2015-04-20 | 2016-10-27 | S-Biomedic Nv | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains |
| CN105168077A (zh) * | 2015-08-14 | 2015-12-23 | 无限极（中国）有限公司 | 一种皮肤护理组合物及其应用、制备方法、产品 |
| WO2017044835A1 (en) | 2015-09-10 | 2017-03-16 | Xycrobe Therapeutics, Inc. | Genetically modified bacteria, compositions and methods of making and using |
| JP2019509263A (ja) * | 2016-02-05 | 2019-04-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 皮膚の健康増進用組成物及び健康増進方法 |
| WO2017147507A1 (en) | 2016-02-24 | 2017-08-31 | Xycrobe Therapeutics, Inc. | Skin probiotic formulation |
| ITUA20162141A1 (it) | 2016-03-31 | 2017-10-01 | Bormioli Pharma Spa | Capsula di chiusura |
| US20190336542A1 (en) | 2016-04-21 | 2019-11-07 | Naked Biome, Inc. | Synthetic bacteria and methods of use |
| EP3445448A4 (en) | 2016-04-21 | 2020-03-18 | Naked Biome, Inc. | THERAPEUTIC AGENTS FOR SKIN CONDITIONS AND METHODS OF USE |
| US9889165B2 (en) | 2016-04-21 | 2018-02-13 | Naked Biome, Inc. | Compositions and methods for treatment of skin disorders |
| IT201600097495A1 (it) | 2016-09-28 | 2018-03-28 | Bormioli Pharma S R L | Capsula con struttura di contenimento e rilascio di un prodotto |
| ES2967029T3 (es) * | 2016-10-19 | 2024-04-25 | S Biomedic Nv | Métodos y composiciones para cambiar la composición del microbioma de la piel usando mezclas complejas de cepas bacterianas |
| US11103443B2 (en) | 2017-05-22 | 2021-08-31 | Dermala | Compositions and methods for preventing, slowing, and reversing skin aging |
| MX2020013073A (es) | 2018-06-14 | 2021-05-27 | Beiersdorf Ag | Preparacion cosmetica contra el acne. |
| JP7532361B2 (ja) | 2018-11-16 | 2024-08-13 | エス－バイオメディック・エン．ヴェー． | 酸化ストレスに関連付けられる皮膚疾患及び皮膚老化を処置するための組成物ならびに酸化ストレスに関連付けられる皮膚疾患の診断。 |
| CN114901246A (zh) | 2019-10-03 | 2022-08-12 | S-生物医药有限公司 | 新的皮肤护理组合物 |
| CN114901252A (zh) | 2019-10-03 | 2022-08-12 | S-生物医药有限公司 | 新的皮肤护理组合物 |
| BR112022006345A2 (pt) | 2019-10-03 | 2022-06-28 | S Biomedic | Composição inovadora para cuidados com a pele |
| CN114929193A (zh) | 2019-10-03 | 2022-08-19 | S-生物医药有限公司 | 新的皮肤护理组合物 |
| BR112022006342A2 (pt) | 2019-10-03 | 2022-06-28 | S Biomedic | Composição inovadora de cuidados com a pele |
| BR112022006369A2 (pt) | 2019-10-03 | 2022-06-28 | S Biomedic | Composição inovadora para cuidados com a pele |
| US20220354776A1 (en) * | 2019-10-03 | 2022-11-10 | Beiersdorf Ag | Novel skin care composition |
-
2017
- 2017-10-19 ES ES21178348T patent/ES2967029T3/es active Active
- 2017-10-19 WO PCT/IB2017/001481 patent/WO2018073651A1/en unknown
- 2017-10-19 JP JP2019521785A patent/JP7235654B2/ja active Active
- 2017-10-19 US US16/343,277 patent/US11541081B2/en active Active
- 2017-10-19 MX MX2019004611A patent/MX2019004611A/es unknown
- 2017-10-19 PL PL17835861T patent/PL3528825T3/pl unknown
- 2017-10-19 KR KR1020197014360A patent/KR102584057B1/ko active IP Right Grant
- 2017-10-19 DK DK17835861.0T patent/DK3528825T3/da active
- 2017-10-19 ES ES17835861T patent/ES2894498T3/es active Active
- 2017-10-19 PL PL21178348.5T patent/PL3912630T3/pl unknown
- 2017-10-19 CN CN201780078504.7A patent/CN110352065A/zh active Pending
- 2017-10-19 EP EP17835861.0A patent/EP3528825B1/en active Active
- 2017-10-19 CA CA3040814A patent/CA3040814A1/en active Pending
- 2017-10-19 EP EP21178348.5A patent/EP3912630B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018073651A1 (en) | 2018-04-26 |
| US20190314428A1 (en) | 2019-10-17 |
| EP3912630C0 (en) | 2023-10-11 |
| US11541081B2 (en) | 2023-01-03 |
| KR20190084988A (ko) | 2019-07-17 |
| KR102584057B1 (ko) | 2023-09-27 |
| ES2894498T3 (es) | 2022-02-14 |
| JP2019535681A (ja) | 2019-12-12 |
| EP3528825A1 (en) | 2019-08-28 |
| CA3040814A1 (en) | 2018-04-26 |
| US20210187043A9 (en) | 2021-06-24 |
| PL3912630T3 (pl) | 2024-04-15 |
| EP3528825B1 (en) | 2021-07-14 |
| ES2967029T3 (es) | 2024-04-25 |
| MX2019004611A (es) | 2019-09-18 |
| CN110352065A (zh) | 2019-10-18 |
| EP3912630A1 (en) | 2021-11-24 |
| PL3528825T3 (pl) | 2022-01-31 |
| JP7235654B2 (ja) | 2023-03-08 |
| EP3912630B1 (en) | 2023-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3528825T3 (da) | Fremgangsmåder og sammensætninger til ændring af sammensætningen af hudmikrobiomet under anvendelse af komplekse blandinger af bakteriestammer | |
| SG10202100951SA (en) | Chemical compositions and methods of using same | |
| EP3285872A4 (en) | METHODS AND COMPOSITIONS FOR MODIFYING THE COMPOSITION OF THE SKIN MICROBIOMA USING COMPLEX MIXTURES OF BACTERIAL STRAINS | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3445388T3 (da) | Materialer og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK3303317T3 (da) | Fremgangsmåder og sammensætninger til inhibering af interaktionen af menin med MLL-proteiner | |
| DK3490582T3 (da) | Sammensætninger til anvendelse i behandling af myelofibrose | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3119797T3 (da) | Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose | |
| DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
| DK3134130T3 (da) | Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3220741T3 (da) | Sammensætning og kits til hæmning af patogen mikrobiel infektion og fremgangsmåder til anvendelse af samme | |
| DK3277270T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3319948T3 (da) | Acesulfam-kaliumsammensætninger og fremgangsmåder til fremstilling af disse | |
| DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
| DK3102555T3 (da) | Sammensætninger af forbindelser og anvendelser deraf | |
| DK3322695T3 (da) | Acesulfam-kalium-sammensætninger og fremgangsmåder til fremstilling af disse | |
| DK2924093T3 (da) | Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse | |
| DK3081263T3 (da) | Sammensætninger og redskaber til behandling af glaukom | |
| DK3261644T3 (da) | Sammensætninger og fremgangsmåder til behandling af nethindenedbrydning | |
| DK3357343T3 (da) | Fedtsammensætning og fremgangsmåde til fremstilling heraf |